Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of immune system physiology (HP:0010978)help
Parent Node:
expand
Abnormal MHC II surface expression (HP:0031389)help
..Starting node
..expand
Reduced MHC II surface expression (HP:0031390)help
Term ID: 31390
Name: Reduced MHC II surface expression
Synonym:
Definition: A reduction from the normal level of major histocompatibility complex class II molecules expressed at the cell surface.
Comments:
Reference: HP:0031390
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandElevated MHC II surface expression (HP:0031391) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0031390HP:0031390Reduced MHC II surface expression0CIITA CL E G H42617067ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040280 - Obligate118
HP:0031390HP:0031390Reduced MHC II surface expression0RFX5 CL E G H59939986ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040280 - Obligate38
HP:0031390HP:0031390Reduced MHC II surface expression0RFXANK CL E G H86259987ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040280 - Obligate26
HP:0031390HP:0031390Reduced MHC II surface expression0RFXAP CL E G H59949988ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040280 - Obligate34


Genes (4) :CIITA RFX5 RFXANK RFXAP

Diseases (1) :ORPHA:572
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.